Market Closed -
Other stock markets
|
After market 05:14:23 pm | |||
132 USD | +0.15% | 132 | +0.08% |
03:02pm | Merck: new indication approved for Keytruda in Europe | CF |
01:45pm | Merck Says Keytruda Plus Chemotherapy as Neoadjuvant Treatment Receives Approval From European Commission | MT |
- Stock
- Equities
- Stock Merck & Co., Inc. - Nyse
- News Merck & Co., Inc.